为进一步验证齐瑞索韦对于婴幼儿感染RSV的长期治疗效果，研究团队对6个月以下患儿的治疗效果进行亚组分析，并开展长期随访。结果显示，齐瑞索韦治疗急性RSV感染的效果显著，能够有效降低病毒载量。治疗组毛细支气管炎临床评分，呼吸频率、喘息、呼吸肌凹陷等分项评分均显著优于安慰剂组，患儿喘息缓解时间与呼吸肌凹陷缓解时间显著缩短。齐瑞索韦可以降低患儿长期反复喘息和哮喘的风险，提示早期抗病毒治疗可对儿童远期呼吸 ...

Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

New studies on respiratory syncytial virus (RSV) in both adults and young children show that infections are linked to a ...

Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

The U.S. Centers for Disease Control and Prevention's panel of outside experts on Wednesday recommended the use of ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

The number of babies having to be hospitalised in Queensland with respiratory illness is down nearly 70 per cent since a new ...

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...